Item 9 Labs Corp.
INLB · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -11.3% | 13.2% | 25.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 56.1% | 65.7% | 52.4% | 16.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -50.4% | -15.1% | -19.2% | -387% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -117.7% | -60.2% | -64.9% | -461.1% |
| EPS Diluted | -0.058 | -0.034 | -0.033 | -0.19 |
| % Growth | -72.1% | -2.7% | 82.7% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |